Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGEN Repligen Corporation

盘后交易 10-23 17:50:13 EDT

176.93

-1.78

-1.00%

盘后177.86

+0.93+0.53%

17:03 EDT

最高179.54	最低174.90	成交量106.61万
今开178.30	昨收178.71	日振幅2.60%
总市值112.33亿	流通市值107.09亿	总股本6,349万
成交额1.88亿	换手率1.76%	流通股本6,053万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":176.93,"timestamp":1792785600000,"preClose":178.71,"halted":0,"volume":1066113,"hourTrading":{"tag":"盘后","latestPrice":177.86,"preClose":176.93,"latestTime":"17:03 EDT","volume":16970,"amount":3002509.5668,"timestamp":1792789430341,"change":0.93,"changeRate":0.005256,"amplitude":0.005256},"delay":0,"changeRate":-0.009960270829836053,"floatShares":60527700,"shares":63490400,"eps":0.73,"marketStatus":"盘后交易","change":-1.78,"latestTime":"10-23 17:50:13 EDT","open":178.3,"high":179.54,"low":174.9,"amount":188125084.61117998,"amplitude":0.025964,"askPrice":180.38,"askSize":11,"bidPrice":173.48,"bidSize":11,"shortable":3,"etf":0,"ttmEps":0.73,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1792800000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":178.71,"preHourTrading":{"tag":"盘前","latestPrice":185,"preClose":178.71,"latestTime":"09:12 EDT","volume":39,"amount":6978.9603,"timestamp":1792761159403,"change":6.29,"changeRate":0.035197,"amplitude":0.042751},"postHourTrading":{"tag":"盘后","latestPrice":177.86,"preClose":176.93,"latestTime":"17:03 EDT","volume":16970,"amount":3002509.5668,"timestamp":1792789430341,"change":0.93,"changeRate":0.005256,"amplitude":0.005256},"volumeRatio":1.058383,"impliedVol":0.6777,"impliedVolPercentile":0.9681},"requestUrl":"/m/hq/s/RGEN/tweets","defaultTab":"tweets","newsList":[{"id":"1188451701","title":"财报前瞻 | Repligen Corporation本季度营收预计小幅增长，机构观点偏谨慎增持","url":"https://stock-news.laohu8.com/highlight/detail?id=1188451701","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1188451701?lang=zh_cn&edition=full","pubTime":"2026-10-20 10:02","pubTimestamp":1792461773,"startTime":"0","endTime":"0","summary":"Repligen Corporation将于2026年10月27日发布最新季度财报，市场关注收入增速与利润率修复节奏及其对全年指引的影响。市场一致预期本季度公司营收为2.07亿美元，同比增长13.94%；调整后每股收益为0.46美元，同比增长10.11%；息税前利润为2,916.47万美元，同比增长19.87%。上季度公司实现营收2.04亿美元，同比增长11.93%；毛利率53.91%；归属于母公司股东的净利润为500.80万美元，净利率2.45%；调整后每股收益为0.54美元，同比增长45.95%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | Repligen Corporation本季度营收预计小幅增长，机构观点偏谨慎增持","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198295066","title":"异动解读｜Repligen盘中下跌6.33%，完成收购BioLife Solutions后市场反应谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1198295066","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198295066?lang=zh_cn&edition=full","pubTime":"2026-10-07 00:27","pubTimestamp":1791304027,"startTime":"0","endTime":"0","summary":"10月6日，Repligen Corporation盘中下跌6.33%，报177.505美元/股，成交额1.24亿美元。消息面上，公司正式宣布完成对BioLife Solutions的收购，交易估值约15亿美元，以现金加股票方式支付，旨在拓展其在细胞治疗市场的业务布局。根据此前协议，BioLife股东每股可获得11.25美元现金及0.1442股Repligen股票，对应每股估值约31美元。此次收购使Repligen获得BioLife在细胞保存技术、细胞处理工具及高利润率耗材方面的能力，有望完善先进疗法供应链。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Repligen完成收购，股价承压走低","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173519787","title":"异动解读 | Repligen Corporation盘中大涨17.38%，Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1173519787","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173519787?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:30","pubTimestamp":1785249011,"startTime":"0","endTime":"0","summary":"Repligen Corporation(RGEN)今日盘中大涨17.38%，引发市场高度关注。消息面上，公司于今日盘前公布了第二季度财报，业绩全面超出市场预期。财报显示，公司Q2调整后每股收益为0.54美元，远超市场预期的0.45美元，同比大增45.95%；营收达2.041亿美元，高于预期的2.015亿美元，同比增长11.9%。此外，公司还上调了全年业绩指引，预计调整后每股收益为2.03至2.09美元（此前为1.97至2.05美元），营收为8.13亿至8.35亿美元（此前为8.03亿至8.33亿美元），均高于分析师预期。强劲的财报数据及乐观的前景展望共同推动了股价的盘中飙升。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108189033","title":"异动解读｜Repligen盘中上涨15.35%，Q2业绩大超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1108189033","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108189033?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:29","pubTimestamp":1785248963,"startTime":"0","endTime":"0","summary":"7月28日，Repligen盘中上涨15.35%，报149.47美元/股，成交额9878.79万美元。消息面上，公司当日盘前公布第二季度财报，业绩全面超出市场预期。Q2调整后每股收益0.54美元，远超市场预期的0.45美元，同比大增45.95%；营收2.041亿美元，高于预期的2.015亿美元，同比增长11.9%。Repligen是全球生物制剂生产关键设备及耗材的领先供应商，产品覆盖单克隆抗体、重组蛋白、疫苗及细胞与基因疗法等生物制药工艺领域。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183199218","title":"若交易在特定情况下终止，Biolife或需向Repligen支付5900万美元终止费","url":"https://stock-news.laohu8.com/highlight/detail?id=1183199218","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183199218?lang=zh_cn&edition=full","pubTime":"2026-07-22 21:04","pubTimestamp":1784725473,"startTime":"0","endTime":"0","summary":"根据相关协议条款，在某些特定情形下，如果交易被终止，Biolife可能被要求向Repligen Corporation支付一笔高达5900万美元的终止费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0205193047.USD","LU0106261612.USD","LU0205194284.USD","LU1815336091.USD","LU0757428866.USD","BK4121","RGEN","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169933349","title":"Repligen斥资15亿美元收购BioLife，以扩大细胞治疗业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1169933349","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169933349?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:15","pubTimestamp":1784722547,"startTime":"0","endTime":"0","summary":"Repligen Corp周三表示，将以现金加股票方式收购BioLife Solutions，交易估值约为15亿美元，以扩大这家制药设备供应商在快速增长的细胞治疗市场的业务布局。此次收购将使Repligen获得BioLife在细胞保存技术方面的能力，可用于整个生产流程及供应链中的细胞保存，同时还将获得其细胞处理工具产品组合以及利润率较高的耗材业务。根据交易条款，BioLife股东每持有一股BioLife股票，将获得11.25美元现金以及0.1442股Repligen股票，对应BioLife每股估值约为31美元，较该公司上一交易日收盘价溢价约6.2%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7cb15f3cc7d8054b7829af808afcb782","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7cb15f3cc7d8054b7829af808afcb782"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Repligen斥资15亿美元收购BioLife，以扩大细胞治疗业务","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN","BLFS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1174553516","title":"Repligen将收购BioLife Solutions，通过市场领先的生物保存介质拓展其细胞疗法能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1174553516","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174553516?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:02","pubTimestamp":1784714521,"startTime":"0","endTime":"0","summary":"Repligen Corporation（RGEN）已同意收购BioLife Solutions Inc.（BLFS），此举旨在通过整合后者市场领先的生物保存介质产品，显著增强其在细胞治疗领域的技术与业务能力。这项交易将Repligen在生物工艺领域的专长与BioLife Solutions在细胞与基因治疗低温保存解决方案方面的领导地位相结合，预计将创造更完整的供应链产品组合，服务于快速增长的先进疗法市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0205193047.USD","LU0205194284.USD","LU1169590202.USD","LU1815336091.USD","LU0012050646.USD","LU0757428866.USD","RGEN","LU1169589451.USD","BK4121","BLFS","LU0106261612.USD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134464808","title":"异动解读｜Repligen Corporation盘中上涨6.57%，报147.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134464808","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134464808?lang=zh_cn&edition=full","pubTime":"2026-06-26 00:15","pubTimestamp":1782404130,"startTime":"0","endTime":"0","summary":"6月26日，Repligen Corporation盘中上涨6.57%，报147.52美元/股，成交额1.05亿美元。Repligen Corporation所在的生命科学工具和服务行业中，整体表现强势，个股中，Techne Corporation涨19.7%，赛默飞世尔涨3.78%，丹纳赫涨3.12%，Tempus AI涨5.04%，Illumina涨3.25%。Repligen Corporation是生物制剂生产关键产品的领先供应商，专注于生物工艺技术，为主要生命科学公司生产Protein A等核心产品，同时直接向终端用户销售生物加工设备和用品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139383641","title":"谷歌母公司Alphabet披露持仓变动：增持PayPay与CME集团，清仓德康医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1139383641","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139383641?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:36","pubTimestamp":1778236606,"startTime":"0","endTime":"0","summary":"根据最新提交的监管文件显示，Alphabet公司在截至2026年3月31日的季度内对其投资组合进行了显著调整。这家科技巨头披露持有PayPay公司310万份赞助存托凭证，同时增持Planet Labs Pbc公司10.4%的A类股份，使其总持股量达到3520万股。在金融领域，Alphabet报告持有芝加哥商品交易所约350万股股份。此外，Alphabet还披露持有Ethos Technologies公司380万份A类股份，同时将其在Revolution Medicines公司的持股比例削减1.6%，目前持有330万股。这些持仓变动均以2025年12月31日为基准进行对比。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU1989772923.USD","LU2362540622.SGD","LU1951200564.SGD","LU2462157665.USD","LU1868836591.USD","IE00B19Z9505.USD","LU1435385759.SGD","LU0426412945.USD","IE000BZT7R73.USD","LU2347655156.SGD","LU0823421333.USD","LU1642822529.SGD","GOOGL","LU0157215616.USD","LU2462591350.SGD","LU0029864427.USD","LU2236285917.USD","LU0950375773.USD","BK4550","LU0708995401.HKD","LU2362541513.USD","IE0004086264.USD","LU1914381329.SGD","LU2111349929.HKD","IE00BQXX3D17.EUR","LU0354030511.USD","LU0310799852.SGD","LU0061474960.USD","LU1699723380.USD","LU1720051108.HKD","IE00BJLML261.HKD","BK4543","LU2456880835.USD","LU0690374961.EUR","IE00BMPRXQ63.HKD","BK4139","BK4563","LU0175139822.USD","LU1791710400.SGD","LU2125154778.USD","LU0106261372.USD","LU1880398554.USD","LU1481011671.HKD","LU1645745479.HKD","WGS","IE00BLSP4452.SGD","LU1003077747.HKD","FULC","LU0215105999.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","CME","IE000MB6IJN5.SGD","IE00BDRTCR15.USD","LU0964807845.USD","LU1119994496.HKD","LU0320765059.SGD","LU2271345857.HKD","LU1935042991.SGD","LU2023250504.SGD","LU1718418525.SGD","LU0310800965.SGD","LU0203347892.USD","RGEN","LU2065170008.USD","IE00B19Z3581.USD","BK4533","LU0476273544.USD","IE00BJTD4V19.USD","IE00BDCRKT87.USD","LU0130102774.USD","LU1366192091.USD","LU1670628061.USD","IE00BKDWB100.SGD","LU1430594728.SGD","LU0154236417.USD","LU0265550946.USD","LU0795875086.SGD","IE00BKPKM429.USD","LU1633808545.USD","LU2065171311.SGD","LU0731783048.USD","LU2095319765.USD","LU1935042215.USD","IE00BK4W5L77.USD","LU0097036916.USD","LU0312595415.SGD","LU0912757837.SGD","DXCM","LU0127658192.USD","LU0976567544.SGD","LU2264538146.SGD","BK4007","LU1145028129.USD","LU0943347566.SGD","LU1235294995.USD","LU1868836757.USD","LU0683600562.USD","LU2746668974.SGD","LU1935043023.USD","LU0772969993.USD","LU1244550577.SGD","LU0477156953.USD","LU2133065610.SGD","LU0109391861.USD","IE00BVYPNW00.USD","LU2097344357.USD","LU1201861249.SGD","LU0757428866.USD","LU0444973449.USD","SG9999014898.SGD","LU0545562505.USD","LU0107464264.USD","BK4576","BK4548","LU0267386448.USD","LU2430703095.HKD","LU1852331112.SGD","LU2125154935.USD","SG9999015978.USD","LU0784385170.HKD","LU2491050154.USD","IE00BK4W5M84.HKD","IE0002270589.USD","LU1815333072.USD","LU0211326839.USD","GOOW","LU1116320901.HKD","BK4566","LU2092627202.USD","LU2092937148.SGD","LU0949170426.SGD","LU1551013425.SGD","LU1989772840.SGD","HK0000304805.HKD","BK4602","IE00BVYPNV92.GBP","LU0048584097.USD","LU1670756490.USD","LU0942090050.USD","IE00B42XCP33.USD","GGLL","LU0882574139.USD","BK4579","IE00B1BXHZ80.USD","LU2750360997.AUD","LU1244550221.USD","LU1989764664.SGD","LU0198837287.USD","LU0130103400.USD","LU1974910355.USD","SG9999018865.SGD","IE00BKVL7J92.USD","BK4503","LU0310800379.SGD","LU2506952097.USD","LU1232071149.USD","LU0787776722.HKD","LU1064131342.USD","LU1720051017.SGD","LU2275660780.HKD","LU1935043536.SGD","LU1043141123.HKD","LU1196500208.SGD","BK4534","LU0784385840.USD","LU2023250330.USD","IE00B19Z8X17.USD","LU2860962120.EUR","PAYP","LU2065169927.USD","SG9999000418.SGD","HK0000532082.HKD","LU0868494708.USD","LU1323610961.USD","LU1894683348.USD","LU0820562030.AUD","LU0006306889.USD","LU0868494617.USD","LU1301847155.USD","IE000M9KFDE8.USD","LU1917777945.USD","LU1951198990.SGD","LU0094547139.USD","LU2471134796.USD","LU1267930730.SGD","LU1988902786.USD","LU2403377893.USD","LU0203345920.USD","BK4585","IE0034235303.USD","IE00B3T34201.USD","LU2506951875.HKD","LU1280957306.USD","LU2054465674.USD","IE0001KFT4U8.USD","LU2756315664.SGD","LU1046421795.USD","LU0149725797.USD","LU2362541273.HKD","LU0061475181.USD","LU0792757196.USD","LU2491049909.HKD","BK4527","LU2506952170.USD","LU0158827781.USD","LU0061474705.USD","LU0689472784.USD","LU0158827948.USD","BK4551","LU0080751232.USD","LU1202635105.USD","LU0265550359.USD","LU1116320737.USD","LU1551013342.USD","LU0056508442.USD","LU2125909593.SGD","LU1066051498.USD","LU2168564222.USD","LU1366333091.USD","LU0823417653.USD","LU2265009873.SGD","LU1267930813.SGD","LU2242650005.HKD","LU1244550494.USD","LU2168564065.EUR","LU1066051811.HKD","LU0345774391.USD","LU1066051225.USD","LU0648000940.SGD","LU0345769128.USD","IE00BZ1G4Q59.USD","LU0320765489.SGD","LU1778281490.HKD","BK4112","IE0034235188.USD","LU0174119429.USD","LU0289739343.SGD","LU0211328371.USD","LU0820561818.USD","IE00BN8TJ469.HKD","LU1923622614.USD","LU2592432038.USD","LU2210149790.SGD","PL","LU2756315318.SGD","LU1868837136.USD","LU0642271901.SGD","LU2089283258.USD","LU0690374615.EUR","LU0494093205.USD","LU2237438978.USD","LU2602419157.SGD","LU2210150020.SGD","LU1629891620.HKD","LU1732799900.SGD","LU2360106780.USD","BK4598","LU0784384876.USD","LU1923623000.USD","LU0211327993.USD","LU0640476718.USD","SGXZ51526630.SGD","LU0314104364.USD","LU0731783394.SGD","LU1043141396.HKD","LU0345770308.USD","LU2491050071.SGD","LU2326559502.SGD","LU0708994859.HKD","LU2168564495.EUR","LU2089284900.SGD","LU2247934214.USD","BK4227","LU0661504455.SGD","LU1506573853.SGD","LU0234572021.USD","BK4082","LU2954938101.SGD","LU0187121727.USD","LU1894683264.USD","LU0052756011.USD","LU0069063385.USD","LU0256863902.USD","IE00BJTD4N35.SGD","LU0823434583.USD","LU2098885051.SGD","LU1228905037.USD","LU2430703178.SGD","LU1509826696.USD","BK4612","IE00B7SZLL34.SGD","LU0256863811.USD","HK0000304797.USD","LU0128525689.USD","BK4532","LU0353189680.USD","LU0345770993.USD","SG9999017495.SGD","LU0314106906.USD","LU0472753341.HKD","LU0545039389.USD","BK4574","LU0557290698.USD","BK4196","LU0345769631.USD","GB00B4LPDJ14.GBP","LU2106854487.HKD","BK4561","LU1804176565.USD","LU1267930227.SGD","LU1221951129.SGD","LU2750360641.GBP","LU0417517546.SGD","LU0444971666.USD","IE00B1XK9C88.USD","LU0985320562.USD","LU1599440770.SGD","GOOP","LU0143551892.USD","GGLS","LU0096364046.USD","LU2420271590.USD","LU2471134952.CNY","SG9999015986.USD","IE0000B7K699.USD","BK4588","LU1803068623.USD","LU0316494557.USD","LU2211815571.USD","LU1571399168.USD","IE00BDGV0183.EUR","LU0353189763.USD","LU1791710582.SGD","LU0208291251.USD","BK4581","LU2746668461.USD","LU2381873111.SGD","LU1059921491.USD","GOOX","LU1815336760.USD","SGXZ99366536.SGD","LU0323591593.USD","LU2430703251.USD","IE000SO60NU8.SGD","LU0477156797.USD","LU1481011911.USD","LU0106261612.USD","LU2168564149.EUR","IE00BSNM7G36.USD","LU1674673691.USD","LU0011850046.USD","LU0957808578.USD","SG9999014906.USD","LU0528227936.USD","IE00B3PB1722.GBP","LU2433249047.HKD","LU1400636574.HKD","IE00BWXC8680.SGD","LU2077746001.SGD","IE00B19Z8W00.USD","LU0266013472.USD","LU0138981039.USD","LU0784383803.USD","GOOY","LU1261432733.SGD","LU1153585028.USD","LU1316542783.SGD","BK4538","LU0289960550.SGD","LU0251142724.SGD","LU2168563687.JPY","LU2191332357.HKD","LU2506951958.HKD","LU0345774631.USD","LU0124676726.USD","LU1815336091.USD","LU2505996681.GBP","LU0057025933.USD","LU1670627923.USD","LU1674673428.USD","IE00BFMHRM44.USD","SG9999015952.SGD","LU0251131958.USD","LU2404859667.USD","LU2087621335.USD","LU1400636657.SGD","LU0348723411.USD","LU2471134879.HKD","LIFE","LU0012050646.USD","LU0302445910.USD","LU1823568750.SGD","BK4173","LU0980610538.SGD","IE0004091025.USD","LU1084165304.USD","RVMD","LU0211331839.USD","IE000WAW04H5.SGD","IE00BQXX3F31.USD","BK4514","LU2357305700.SGD","LU2471134523.USD","LU0795875169.SGD","LU2063271972.USD","LU1839511570.USD","LU1121112475.USD","BK4121","LU1868836914.USD","LU0210533765.USD","LU0096362180.USD","LU2097344431.USD","LU2404859741.USD","BK4592","LU0426417589.USD","LU1868837300.USD","LU0251132253.USD","LU2250418816.HKD","LU0742534661.SGD","LU1548497426.USD","LU0345768740.USD","LU2028103732.USD","LU0234570918.USD","LU0466842654.USD","LU0738911758.USD","LU1585245621.USD","LU2023251221.USD","SG9999014880.SGD","LU0742537680.HKD","LU0342679015.USD","BK4123","LU0130517989.USD","LU0672654240.SGD","LU1267930573.SGD","LU2213496289.HKD","SG9999018857.SGD","LU1228905540.USD","LU0820561909.HKD","LU0225283273.USD","LU2462591277.SGD","LU0130518102.USD","LU0889566641.SGD","LU1496350502.SGD","LU2999663052.SGD","LU2505996509.AUD","IE00BBT3K403.USD","LU0345768153.USD","LU2360032135.SGD","LU2417539215.USD","LU2065171402.SGD","LU1303367103.USD","LU1496350171.SGD","LU0070302665.USD","LU1267930490.SGD","LU2097829019.USD","LU2242649171.HKD","LU1201861165.SGD","LU0496365809.HKD","IE00BMPRXN33.USD","HK0000819398.USD","IE00BMPRXR70.SGD","LU0128525929.USD","GB00B4QBRK32.GBP","IE00BYXW3230.USD","LU1935042488.USD","IE000F7OJYX1.SGD","LU0211326755.USD","LU0823417737.USD","LU1732800096.USD","LU0823421416.USD","LU2023250843.SGD","LU0276348264.USD","LU0289961442.SGD","LU2087625088.SGD","LU0689626769.HKD","LU2125909247.SGD","SG9999014914.USD","LU0823434740.USD","LU0170899867.USD","IE0034235295.USD","IE00BGHQF631.EUR","IE00BQXX3C00.GBP","GOU","LU0957791311.USD","SGXZ31699556.SGD","LU0077335932.USD","LU0354030438.USD","LU1032955483.USD","LU1989764748.USD","LU0949170772.SGD","PLU","LU1429558221.USD","BK4573","LU0048573561.USD","LU0553294199.USD","LU1400636491.USD","SGXZ81514606.USD","LU0511384066.AUD","LU1066053197.SGD","IE00BLSP4239.USD","LU1880398471.USD","LU0648001328.SGD","LU0994945656.USD","LU2244417387.USD","IE00BHPRN162.USD","LU1221951046.USD","LU0070217475.USD","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146420854","title":"财报前瞻｜Repligen Corporation本季度营收预计增17.36%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1146420854","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146420854?lang=zh_cn&edition=full","pubTime":"2026-04-28 11:49","pubTimestamp":1777348196,"startTime":"0","endTime":"0","summary":"Repligen Corporation将于2026年05月05日发布财报，市场关注收入与盈利修复的力度及关键产品线表现。上季度公司实现营收1.98亿美元，同比增长18.12%，毛利率52.46%，归属于母公司净利润为1,328.70万美元，净利率6.71%，调整后每股收益为0.49美元，同比增长11.36%。上季度毛利率为52.46%，结合本季度收入预计同比增长17.36%，若制造稼动率提升与原材料价格稳定，单位制造成本下压将带来毛利率边际改善的空间。近期主流机构对Repligen Corporation观点偏正面，看多意见占比更高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Repligen Corporation本季度营收预计增17.36%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518827601","title":"Repligen Corporation盘中异动 快速下跌5.17%报147.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518827601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518827601?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:52","pubTimestamp":1741614761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时52分，Repligen Corporation股票出现异动，股价急速跳水5.17%。截至发稿，该股报147.65美元/股，成交量7.3314万股，换手率0.13%，振幅2.90%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.40%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","RGEN","BK4121","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517605707","title":"Repligen Corporation盘中异动 股价大跌5.16%报147.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517605707?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:47","pubTimestamp":1741103262,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时47分，Repligen Corporation股票出现波动，股价大幅下跌5.16%。截至发稿，该股报147.37美元/股，成交量11.4499万股，换手率0.20%，振幅4.70%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.24%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","RGEN","BK4121","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703863","title":"Repligen Corporation盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514703863?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:06","pubTimestamp":1740427594,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时06分，Repligen Corporation股票出现波动，股价快速拉升5.01%。截至发稿，该股报166.96美元/股，成交量47.4486万股，换手率0.85%，振幅5.20%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.23%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","RGEN","BK4121","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513097291","title":"小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513097291","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513097291?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:22","pubTimestamp":1740151334,"startTime":"0","endTime":"0","summary":"小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21232248320493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513262262","title":"加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262262","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513262262?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:40","pubTimestamp":1740141632,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21204048318756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103076426","title":"异动解读 | Repligen公司2024年Q4财报超预期,股价盘中涨逾9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103076426","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103076426?lang=zh_cn&edition=full","pubTime":"2025-02-21 03:48","pubTimestamp":1740080910,"startTime":"0","endTime":"0","summary":"上市生物科技公司Repligen(RGEN)今日盘中大涨9.48%,引发市场关注。这主要是由于公司新发布的2024年第四季度财报数据好于预期,带来了利好消息。\n\n根据财报显示,Repligen公司第四季度每股收益为0.44美元,超出了分析师预期的0.41美元。尽管公司当季销售额略低于预期,但盈利能力的显著提升,显示了公司良好的运营状况。\n\n分析人士认为,Repligen公司业绩超预期,增强了投资者对公司长期发展前景的信心。市场预期该公司将继续保持良好的增长动能,成为资本市场中的投资热点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179131861","title":"异动解读 | Repligen公司盘前大涨9.47%，业绩超预期带来市场利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1179131861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179131861?lang=zh_cn&edition=full","pubTime":"2025-02-20 21:54","pubTimestamp":1740059678,"startTime":"0","endTime":"0","summary":"上市生物科技公司Repligen(RGEN)今日盘前大涨9.47%,引发了市场投资者的广泛关注。\n\n消息面上,Repligen公司最新公布的2024年第四季度财报显示,公司当季每股收益为0.44美元,超出了分析师预期的0.41美元,同时公司销售额也略高于去年同期。尽管销售额低于分析师预期,但盈利能力的增长仍彰显出公司良好的运营状况。\n\n分析人士认为,Repligen公司的季度业绩好于市场预期,显示公司具有强劲的利润增长动力,这增强了投资者对公司长期前景的信心,从而刺激了公司股价在盘前大幅走高。展望未来,公司有望继续保持良好的业绩增长,成为资本市场的投资热点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124711795","title":"Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124711795","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124711795?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:39","pubTimestamp":1740055154,"startTime":"0","endTime":"0","summary":"Repligen  报告其季度每股收益为0.44美元，高于分析师普遍预期的0.41美元，高出7.32%。公司报告其季度销售额为1.6755亿美元，低于分析师普遍预期的1.6767亿美元，低出0.07%。与去年同期的销售额1.6662亿美元相比，增长了0.56%。以上内容来自Benzinga Earnings专栏，原文如下：Repligen  reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.41 by 7.32 percent. This is a 8.33 percent decrease over earnings of $0.48 per share from the same period last year.  The company reported quarterly sales of $167.55 million which missed the analyst consensus estimate of $167.67 mill","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507650584","title":"Repligen Corporation盘中异动 下午盘急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507650584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507650584?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:06","pubTimestamp":1738177586,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时06分，Repligen Corporation股票出现波动，股价快速下挫5.10%。截至发稿，该股报165.36美元/股，成交量46.3634万股，换手率0.83%，振幅5.18%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.28%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030627a2339427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030627a2339427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","LU1815336091.USD","RGEN","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506751752","title":"Repligen Corporation盘中异动 快速上涨6.24%报178.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506751752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506751752?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074672,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Repligen Corporation股票出现异动，股价大幅拉升6.24%。截至发稿，该股报178.50美元/股，成交量3.5001万股，换手率0.06%，振幅0.00%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.61%。其相关个股中，Daxor Corporation、Repligen Corporation、Avantor, Inc.涨幅较大，Sharps Technology Inc.、Glucotrack, Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为223.91%、9.98%、0.89%，振幅较大的相关个股有Glucotrack, Inc.、Zentek Ltd.、Daxor Corporation，振幅分别为2.52%、1.75%、1.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822311298756b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822311298756b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU1815336091.USD","LU0757428866.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0431},{"period":"3month","weight":0.3543},{"period":"6month","weight":0.5196},{"period":"1year","weight":0.1353},{"period":"ytd","weight":0.0906}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0122},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.0701},{"period":"1year","weight":0.144},{"period":"ytd","weight":0.1203}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation成立于1981年5月。该公司是生物制剂生产关键产品的领先供应商。公司根据长期供应协议为主要生命科学公司生产Protein A，同时也直接向终端用户销售产品，供其生产工艺使用。公司还将其在生物制品开发方面的专业知识应用于SecreFlo的研发。SecreFlo是公司正在开发的一种合成人激素，旨在作为一种新型显像剂用于诊断胰腺炎以及潜在的多种胰腺疾病。该公司目前还有两项针对弗里德赖希氏共济失调和脊髓性肌萎缩症的早期中枢神经系统罕见病项目正在进行中，并已进入I期临床试验阶段。此外，该公司已将部分知识产权授权给Bristol-Myers Squibb Company，并从该公司在美国销售的Orencia产品净销售额中获得特许权使用费。","yearOnYearQuotes":[{"month":1,"riseRate":0.675,"avgChangeRate":0.091484},{"month":2,"riseRate":0.4,"avgChangeRate":0.02561},{"month":3,"riseRate":0.525,"avgChangeRate":0.031522},{"month":4,"riseRate":0.5,"avgChangeRate":-0.003105},{"month":5,"riseRate":0.560976,"avgChangeRate":0.045895},{"month":6,"riseRate":0.487805,"avgChangeRate":-0.008423},{"month":7,"riseRate":0.512195,"avgChangeRate":0.029399},{"month":8,"riseRate":0.585366,"avgChangeRate":0.036134},{"month":9,"riseRate":0.390244,"avgChangeRate":-0.034091},{"month":10,"riseRate":0.463415,"avgChangeRate":0.023369},{"month":11,"riseRate":0.475,"avgChangeRate":0.032931},{"month":12,"riseRate":0.475,"avgChangeRate":-0.003719}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}